IPO Weekly Recap: 4.10.2015 – Carbylan opens higher

This past week two IPOs debuted, six updated terms and seven new deals filed.

It was a very quiet week on the IPO front as just two deals debuted. After a lengthy delay and amended terms Carbylan Therapeutics (Nasdaq: CBYL) priced an up-sized offering at $5.00. The deal opened 30% higher with a first trade of $6.50.

It should be noted that a deal that has been on the rocks for a couple of weeks, ViewRay (Nasdaq: VRAY), was officially postponed by the underwriter ‘due to market conditions’. There is no further information at this time.

Looking ahead to this week we are hearing good, early buzz about….(SUBSCRIPTION NEEDED).

Here’s a look at all the deals for next week.

Please check your emails early and often. We may upgrade or downgrade an IPO and or secondary –sometimes with not as much notice as we would like to give. If you have interest in IPOs do NOT delay your IOI’s (hopefully they are already in)…you can always cancel them. We will keep you posted if and as when…we have anything pertinent to add. The current number of “active” IPOs in the pipeline as of 4/10/15 is 137.  Good luck trading!